Supplementary materials for A Phase III Study to Compare Efficacy and Safety of BAT2206 (Proposed Ustekinumab Biosimilar) with Reference Ustekinumab in Patients with Moderate to Severe Plaque Psoriasis
收藏doi.org2025-03-25 收录
下载链接：
http://doi.org/10.17632/w2vksw3xdd.3
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary tables
补充表格
提供机构：
doi.org
